UNDERWRITING AGREEMENT between HCW BIOLOGICS INC. and EF HUTTON DIVISION OF BENCHMARK INVESTMENTS, LLC AS REPRESENTATIVE OF THE SEVERAL UNDERWRITERSUnderwriting Agreement • July 9th, 2021 • HCW Biologics Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 9th, 2021 Company Industry JurisdictionThe undersigned, HCW Biologics Inc., a corporation formed under the laws of the State of Delaware (the “Company”), hereby confirms its agreement (this “Agreement”) with EF Hutton, division of Benchmark Investments, LLC, (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows: